2017
DOI: 10.1136/gutjnl-2016-312270
|View full text |Cite
|
Sign up to set email alerts
|

miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis

Abstract: Background and aimsHCV infection is a leading risk factor of hepatocellular carcinoma (HCC). However, even after viral clearance, HCC risk remains elevated. HCV perturbs host cell signalling to maintain infection, and derailed signalling circuitry is a key driver of carcinogenesis. Since protein phosphatases are regulators of signalling events, we aimed to identify phosphatases that respond to HCV infection with relevance for hepatocarcinogenesis.MethodsWe assessed mRNA and microRNA (miRNA) expression profiles… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
67
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(68 citation statements)
references
References 50 publications
0
67
0
1
Order By: Relevance
“…Other miRNAs, including miR-155, miR-146a-5p, miR-135a-5p and miR-373, were shown to either promote or inhibit HCV-associated hepatocarcinogenesis. (45)(46)(47)(48) Our study highlighted how intratumoral introduction of synthetic miR-181c inhibits tumor progression in a HCC xenograft tumor model. Recent introduction of direct-acting antivirals (DAAs) with the combinations of virus replication inhibitors may achieve a decrease in virus titer to a sustained virological response in HCV-infected patients.…”
Section: Discussionmentioning
confidence: 88%
“…Other miRNAs, including miR-155, miR-146a-5p, miR-135a-5p and miR-373, were shown to either promote or inhibit HCV-associated hepatocarcinogenesis. (45)(46)(47)(48) Our study highlighted how intratumoral introduction of synthetic miR-181c inhibits tumor progression in a HCC xenograft tumor model. Recent introduction of direct-acting antivirals (DAAs) with the combinations of virus replication inhibitors may achieve a decrease in virus titer to a sustained virological response in HCV-infected patients.…”
Section: Discussionmentioning
confidence: 88%
“…Third, RNA-Seq has a better accuracy and repeatability [9][10][11][12]. Advances in RNA-Seq have enabled the examination of HCC at high resolution [13][14][15][16][17].…”
Section: Discussionmentioning
confidence: 99%
“…Increasingly, dysregulated miRNAs are being found in virus-infected cells, which results in interference with several immune-related signaling pathways, and exert their functions in many pathophysiological processes, such as the JAK-STAT signaling pathway (SOCS3, STAT3, IFN), cytokine-cytokine receptor interaction (IL-6, IFN-␥), and T-cell receptor signaling pathways (IL-10) (34). miR-135a-5p is a negative regulator of STAT3 phosphatase PTPRD and is upregulated in HCV-infected hepatocytes, leading to enhanced STAT3 transcription (49). Some miRNAs, including miR-124, miR-20, and miR-29a, have been reported to be altered in RABV-infected mouse brain and neurons and have been predicted to contribute to immune modulation (34,35,50).…”
Section: Discussionmentioning
confidence: 99%